IJCM  Vol.9 No.10 , October 2018
PET/CT and Hypo-Fractionated Radiotherapy of Patients with Head and Neck Cancer
Abstract: Positron emission tomography/Computer tomography (PET/CT) is a multimodality imaging diagnostic technique that analyzes the uptake and retention of different radiopharmaceuticals by cells providing metabolic information on biochemical processes. PET/CT has been used for radiotherapy planning, providing useful information to the Radio-oncologist about the localization, size and metabolic activity of tumor lesions. In this paper, we show advantages of the 18F-FDG PET/CT respect to simple CT imaging for target volume delineation in patients with diagnosis of Squamous Head and Neck Carcinoma that has been scheduled to undergo a hypofractionated radiotherapy treatment. On ten studied patients, the target volume defined from PET/CT images was less extensive than those defined from simple CT images. In six patients the target volume was significantly less extensive and in two of them a new lymph node disease was reported, re-staging and corresponding target volume was also delineated with less extensive margins from PET/CT images. A greater accuracy in delineating the volumes and improving the distribution of doses in the planning of the radiant treatment in these patients was possible, allowing a high precision in the delivery of the prescribed dose to the target volume diminishing the maximum dose to the adjacent healthy tissues. In conclusion we show that the use of 18F-FDG PET/CT was superior than the simple CT as the primary modality of imaging for hypofractioned radiotherapy treatment planning in patients with Squamous Head and Neck Carcinoma.
Cite this paper: Morales, M. , Ramirez, A. , Glez, J. , Espinosa, C. , González, J. , Marín, C. , Cepero, W. , Reina, F. and Mora, R. (2018) PET/CT and Hypo-Fractionated Radiotherapy of Patients with Head and Neck Cancer. International Journal of Clinical Medicine, 9, 751-759. doi: 10.4236/ijcm.2018.910062.

[1]   Sigel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics 2013. CA: A Cancer Journal for Clinicians, 63, 11-30.

[2]   Boyle, P. and Levin, B. (2008) World Cancer Report 2008. International Agency for Research on Cancer, Lyon.

[3]   NU. CEPAL. Statistics Division (2017) Cuba’s Statistical Yearbook for Latinoamerican and the Caribbean.

[4]   (2017) NCCN Clinical Practice Guidelines in Oncology.

[5]   (2016) National Cancer Institute Guidelines.

[6]   Yoo, J., Henderson, S. and Walker-Dilks, C. (2013) Evidence-Based Guideline Recommendations on the Use of Positron Emission Tomography Imaging in Head and Neck Cancer. Clinical Oncology, 25, e33-e66.

[7]   Eugenio Vinés, V., María José Orellana, G., Catalina Bravo, M. and David Jofré, P. (2017) Manejo del cáncer de cabeza y cuello: Radioterapia a quién, cuándo y por qué? Revista de Otorrinolaringología y Cirugía de Cabeza y Cuello, 77, 81-90.

[8]   Thariat, J., Hannoun-Levi, J.M., Myint, A.S., et al. (2013) Past, Present and Future of Radiotherapy for the Benefitof Patients. Nature Reviews Clinical Oncology, 10, 52-60.

[9]   Das, S., Thomas, S., Pal, S.K., Isiah, R., John, S., et al. (2013) Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience. Indian Journal of Palliative Care, 19, 93-98.

[10]   Grégoire, V., Coche, E., Cosnard, G., Hamoir, M. and Reychler, H. (2000) Selection and Delineation of Lymph Node Target Volumes in Head and Neck Conformal Radiotherapy. Proposal for Standardizing Terminology and Procedure Based on the Surgical Experience. Radiotherapy & Oncology, 56, 5-50.

[11]   Zhu, L. and Wang, N. (2013) 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography as a Diagnostic Tool in Patients with Cervical Nodal Metastases of Unknown Primary Site: A Meta-Analysis. Surgical Oncology, 22, 190-194.

[12]   Cacicedo, J., Navarro, A., Del Hoyo, O., Gomez-Iturriaga, A., Alongi, F., Medina, J.A., et al. (2016) Role of Fluorine-18 Fluorodeoxyglucose PET/CT in Head and Neck Oncology: The Point of View of the Radiation Oncologist. The British Journal of Radiology, 89, Article ID: 20160217.

[13]   Daisne, J.F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., et al. (2004) Tumor Volume in Pharyngolaryngeal Squamous Cell Carcinoma: Comparison at CT, MR Imaging, and FDG PET and Validation with Surgical Specimen. Radiology, 233, 93-100.

[14]   Geets, X., Lee, J.A., Bol, A., Lonneux, M. and Grégoire, V. (2007) A Gradient-Based Method for Segmenting FDG-PET Images: Methodology and Validation. European Journal of Nuclear Medicine and Molecular Imaging, 34, 1427-1438.

[15]   Leclerc, M., Lartigau, E., Lacornerie, T., Daisne, J.F., Kramar, A. and Gregoire, V. (2015) Primary Tumor Delineation Based on (18) FDG PET for Locally Advanced Head and Neck Cancer Treated by Chemo-Radiotherapy. Radiotherapy & Oncology, 116, 87-93.

[16]   Deantonio, L., Beldi, D., Gambaro, G., Loi, G., Brambilla, M., Inglese, E., et al. (2008) FDG-PET/CT Imaging for Staging and Radiotherapy Treatment Planning of Head and Neckcarcinoma. Radiation Oncology, 3, 29.

[17]   Beswick, D.M., Gooding, W.E., Johnson, J.T. and Branstetter, B.F. (2012) Temporal Patterns of Head and Neck Squamous Cell Carcinoma Recurrence with Positron-Emission Tomography/Computed Tomography Monitoring. Laryngoscope, 122, 1512-1517.